Gene Query: FASTKD5

Dataset Description Geneva Score
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 25.07
Effect of FGF13 depletion on the H460 cell line 17.02
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 16.16
A transcriptome-wide divergence in protein translation scales with LIN28B expression 15.78
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 14.13
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 14.13
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 13.75
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 13.54
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 13.27
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 12.83
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 11.91
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 11.75
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 10.23
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 9.83
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 9.19
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 9.01
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 9.01
SRSF1 role in cellular gene expression and splicing 8.67
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.66
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.66
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 8.45
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 8.38
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 8.08
Transcriptomic analyssis following EHMT1/2 inhibition 8.02
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.0
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.0
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 7.59
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.49
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.48
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.24
Effect of drugs on transcriptomic profiles 7.24
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 7.09
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 7.07
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 7.0
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 7.0
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 7.0
Transcriptional profile in human S. haematobium infection 6.99
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.96
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 6.92
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 6.85
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 6.79
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 6.56
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 6.42
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 6.42
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.42
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.42
RNAseq Study in CC-671 Treated Cal-51 Cells 6.38
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 6.34
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 6.3
FBXW7 modulates stress response by post-translational modification of HSF1 6.3
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.3
RNA-seq data from human lymphoma cell lines 6.25
ChIP-seq and RNA-seq from human lymphoma cell lines 6.25
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 6.21
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 6.21
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.2
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.18
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.17
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.17
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 6.16
Human Treg NaCl stimulation 5.93
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.92
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.74
Gene expression analysis of immortalized human liver progenitor-like cells in culture 5.64
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.57
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 5.52
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 5.5
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 5.5
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 5.46
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 5.31
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.31
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.31
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 5.27
NKX2.2 5.27
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.22
Seletive inhibition of CDK9 in DLBCL cell lines 5.2
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 5.19
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 5.12
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.09
Transcriptome analysis upon C6orf203 silencing 5.07
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 5.06
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 5.04
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.94
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 4.87
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 4.87
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.84
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.82
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 4.75
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 4.74
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 4.74
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.64
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.62
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.6
Noncoding regions are the main source of targetable tumor-specific antigens 4.53
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 4.48
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.44
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 4.44
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 4.27
The evolution of N6-methyladenosine in primates 4.26
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 4.25
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.22
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.22
METTL3 promotes translation in human cancer cells 4.2
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.13
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 4.13
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.12
Cell responses to dysregulated VZV-induced cell-cell fusion 4.09
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.09
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.07
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 4.02
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 4.02
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.0
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.0
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.98
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.98
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.98
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 3.98
A549 cells and MSR-A549 cells 3.98
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.95
The landscape of alternative splicing in aggressive prostate cancers 3.95
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.94
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.94
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 3.91
Control of prostate tumour growth by the long non-coding RNA GHSROS 3.91
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 3.88
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 3.88
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 3.86
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 3.86
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.84
The regulartory role of ZCCHC24 in splicing machinery 3.84
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.84
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 3.83
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 3.83
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 3.82
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 3.82
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 3.81
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.79
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 3.78
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 3.78
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.77
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.77
Effect of disulfiram treatment on pediatric high grade glioma 3.75
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 3.75
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.71
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.7
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.7
Accurate annotation of human protein-coding small open reading frames 3.7
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.69
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 3.67
Trans-differentiation of human adult peripheral blood T cells into neurons 3.66
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 3.66
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.66
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.66
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 3.65
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 3.64
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.64
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.64
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.64
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 3.63
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.61
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 3.6
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 3.59
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 3.58
LIN28A modulates splicing and gene expression programs in breast cancer cells 3.58
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.58
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.58
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.58
Regulation of protein translation during mitosis 3.56
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.55
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.55
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 3.54
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 3.54
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.54
RNA-seq analysis of AML cells in response to ASLAN003 3.51
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 3.5
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.5
UBC9 knockdown in bladder cancer T24 cell lines 3.47
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.45
Gene expression in PANC1 cells treated with Rakicidin 3.42
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 3.4
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.39
Identification of global regulators of T-helper cell lineage specification 3.37
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.37
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 3.36
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 3.35
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 3.35
Effect of Influenza virus infection on lncRNA expression in A549 cells 3.34
Nrf2 regulated genes in A549 cells 3.31
Identification of Nrf2 regulated genes by RNA sequencing 3.31
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 3.3
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.3
Determining mRNA half-lives on a transcriptome-wide scale 3.27
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 3.26
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.23
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 3.22
Iron response of HepG2 cells 3.21
RNA-seq of naive and primed ES cells (NHSM) 3.21
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.21
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.2
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 3.2
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 3.19
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.14
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.12
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.11
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 3.11
AUF-1 affected genes in human skin cells 3.1
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.06
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.05
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.05
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.05
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.04
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.01
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 3.0
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 3.0
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 3.0
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.0
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.0
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.97
Role for citron kinase in prostate cancer growth 2.96
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.95
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 2.95
Functional role of SLIT2 and ROBO1 in trophoblasts 2.93
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.92
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.91
Paxillin regulates genomic networks in prostate cancer [C4-2] 2.89
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.87
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 2.87
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 2.87
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 2.87
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.86
Total RNA-seq in ALL-SIL upon JQ1 inhibition 2.81
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 2.79
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.79
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.78
TGF-β promotes genomic instability after loss of RUNX3 2.76
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 2.76
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.74
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.74
Gene expression analysis upon mtDNA depletion 2.74
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.73
The Genetic Landscape of Diamond-Blackfan Anemia 2.72
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.7
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 2.7
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 2.69
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.67
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.65
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.62
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 2.58
Functional role of CPPED1 in trophoblasts. 2.56
Identification of Sin3B regulated genes during quiescence 2.53
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.52
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 2.49
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 2.49
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 2.49
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.47
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.45
Genome-wide discovery of human splicing branchpoints [RNAse] 2.45
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.43
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 2.41
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.37
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.35
Unique features and clinical importance of acute alloreactive immune responses 2.35
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.32
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.31
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.31
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.31
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 2.3
Identification of HOXB13 target genes responsive to BET inhibitors 2.29
Global analysis of alternative splicing regulated by RBM10 2.28
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.27
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.27
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.27
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.26
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 2.25
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 2.22
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.21
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.2
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.2
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.2
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.19
NHLRC1 re-expression in cancer cells 2.16
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.16
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.15
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.13
PRDM1 inhibits proliferation of human colon cancer organoids 2.11
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.08
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.08
2.07
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 2.06
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.04
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.01
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.0
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 1.99
RNA-seq of cancer cell lines treated with T-025 1.98
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.98
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.97
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.97
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.96
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.95
RNA-seq of resting and activated CD4+ T cells +-JQ1 1.94
Copper Regulation of HIF-1 Transcription Activity 1.93
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.93
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.93
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.92
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.92
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.9
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.89
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 1.89
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.88
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.88
Widespread intronic polyadenylation diversifies immune cell transcriptomes 1.87
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.87
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.87
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.87
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.86
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 1.84
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 1.84
HNRNPM-regulated splicing dependencies in prostate cancer 1.84
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.84
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.84
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.82
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.78
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.75
KSDM1b Role in Ewing Sarcoma 1.74
SLAM-seq for K562 endogenous mRNA decay 1.74
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.71
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.7
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.69
Effect of PBK knockdown on C4-2 cell transcriptome 1.68
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.68
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.67
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.67
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.65
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.62
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.6
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.57
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.53
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.51
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.49
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 1.48
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.45
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 1.44
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 1.44
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.43
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.42
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.42
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.41
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.4
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.39
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.39
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.38
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.38
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.38
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.37
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.37
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.35
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.34
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 1.33
RNA-seq of RKO cells with cTAZ KO or putback 1.33
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.28
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.24
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 1.19
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.18
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.17
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.17
Regulation of hypoxia-inducible factor activity by ZMYND8 1.17
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 1.15
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.13
Single-cell analysis of adult human ovary using 10X genomics 1.13
RNA sequencing of T-ALL (COG study) 1.13
Analyses of T-ALL (COG study) 1.13
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.13
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.13
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.13
HBEC-shp53-PCHD7 1.12
Differential Protein Occupancy Profiling of the mRNA Transcriptome 1.12
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.11
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 1.11
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.11
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.11
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.1
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.1
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.09
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.08
K562 polyA RNA-Seq 1.07
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.03
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.03
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.02
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 1.0
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.99
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.99
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.97
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.96
Functional significance of the HIV-1 Tat signature amino acid residues 0.95
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.92
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.91
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.9
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.89
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.88
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.88
Effect of PRDM11 depletion in U2932 cells 0.87
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.84
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.82
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.81
MAIT cell RNA sequencing 0.81
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.8
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.8
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.8
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.8
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.79
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 0.78
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 0.78
Role of COP1 on MAP kinase transcriptional output in melanoma 0.77
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.77
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.77
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.77
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 0.77
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.75
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.75
RNA seq with AML (NB4) cells upon FTO inhibition 0.73
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.72
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.71
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.7
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.7
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.69
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.68
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 0.66
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 0.65
Human Treg IL-12 stimulation 0.64
Genome-wide analysis of the Integrator complex 0.64
Genome-wide analysis of the Integrator complex (HTS) 0.64
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.63
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.62
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.61
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.56
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.55
Identification of global XBP1s target gene expression in human prostate cancer cells 0.53
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.52
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.49
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.46
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.44
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.44
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.43
The bromodomain protein BRD4 regulates splicing during heat shock 0.41
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.39
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.39
Ribosomal protein RPL26 is the principal target of UFMylation 0.39
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.39
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.38
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.38
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.37
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.37
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.35
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.33
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.33
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.31
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.31
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.3
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.3
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 0.29
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.28
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.28
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.28
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.27
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.25
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.24
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.23
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.23
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.22
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.22
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.2
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.18
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.17
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.17
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.17
Leucegene: AML sequencing (part 6) 0.16
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.15
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.14
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.14
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.12
SNHG5 siRNA knock down in HCT116 cells 0.12
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.12
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.11
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.11
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.11
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.11
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.09
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.09
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.09
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.09
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.09
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.07
Human Treg IFNg/IL-10 subpopulations 0.06
RNA seq analysis of human Fetal and adult derived Enterospheres 0.05
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.05
Downregulation of LATS kinases alters p53 to promote cell migration 0.05
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.04
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.03
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.02
RNA-seq of primary patient AML samples 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation